{
  "ticker": "BOD",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02971510",
  "id": "02971510",
  "pages": 5,
  "price_sensitive": true,
  "date": "20250722",
  "time": "1554",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250722/pdf/06m0zglgsy3b3z.pdf",
  "summary": "**Appendix 4C (Quarterly Cash Flow Report) Summary:**  \n\n- **Cash Position**: Closing cash balance of **A$1.04M** (up from A$179k last quarter).  \n- **Operating Cash Flow**: **Net +A$858k** (QoQ), driven by:  \n  - R&D tax incentive receipt of **A$678k** (A$400k held in trust for Biortica if acquisition completes).  \n  - Biortica funding support (disclosed as \"other\" inflows).  \n- **Key Outflows**: Staff costs (A$236k), admin/corporate costs (A$147k).  \n- **Financing**: No debt facilities drawn; **A$9k repayment** (year-to-date).  \n- **Liquidity**: **Positive operating cash flow** (no quarters of funding estimate required).  \n\n**Material Notes**:  \n1. **Biortica HOA**: Partial funding of operations per Feb 2024 agreement (disclosed in \"other\" inflows).  \n2. **IP Sale**: A$125k received from intellectual property disposal (Q2).  \n\n*Omitted: Routine line items without material impact.*",
  "usage": {
    "prompt_tokens": 2820,
    "completion_tokens": 250,
    "total_tokens": 3070,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-22T06:39:47.812248"
}